Miguel Escalante
Overview
Explore the profile of Miguel Escalante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dube C, Zhang Y, Saha S, Lai M, Gibert M, Escalante M, et al.
bioRxiv
. 2024 Sep;
PMID: 39229003
Background: Glioblastoma (GBM) is the most common primary malignant brain tumor. The aim of this study was to elucidate the role of microenvironment and intrinsic T-type calcium channels (Cav3) in...
2.
Spencer S, Suarez-Pozos E, Escalante M, Myo Y, Fuss B
Neurochem Res
. 2020 Jan;
45(6):1287-1297.
PMID: 31927687
The solute carrier 8 (SLC8) family of sodium-calcium exchangers (NCXs) functions as an essential regulatory system that couples opposite fluxes of sodium and calcium ions across plasmalemmal membranes. NCXs, thereby,...
3.
Thomason E, Escalante M, Osterhout D, Fuss B
Glia
. 2019 Nov;
68(7):1329-1346.
PMID: 31696982
Cells of the oligodendrocyte (OLG) lineage engage in highly motile behaviors that are crucial for effective central nervous system (CNS) myelination. These behaviors include the guided migration of OLG progenitor...
4.
Escalante M, Soto-Verdugo J, Hernandez-Kelly L, Hernandez-Melchor D, Lopez-Bayghen E, Olivares-Banuelos T, et al.
Neurochem Res
. 2019 Aug;
45(6):1365-1374.
PMID: 31363896
Glutamate is the major excitatory amino acid neurotransmitter in the vertebrate brain. It exerts its actions through the activation of specific plasma membrane receptors expressed in neurons and glial cells....
5.
Escalante M, Gagliardino J, Rosas Guzman J, Tschiedel B
Diabetes Res Clin Pract
. 2014 May;
104(3):343-52.
PMID: 24835577
Latin America faces a unique set of challenges in the treatment of type 2 diabetes mellitus (T2DM). This report identifies these challenges and provides a framework for implementation of the...
6.
Guzman-Flores J, Escalante M, Sanchez-Corona J, Garcia-Zapien A, Cruz-Quevedo E, Munoz-Valle J, et al.
J Investig Med
. 2012 Dec;
61(2):265-9.
PMID: 23254337
Background: Gestational diabetes mellitus (GDM) is characterized by insulin resistance. It has been described that tumor necrosis factor α (TNF-α) plays a key role in the pathogenesis of insulin resistance;...